Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

311
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
311
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

262
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
262
Analgesia and Pain Management01:25

Analgesia and Pain Management

636
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
636
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

742
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
742
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

939
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
939
Pharmacovigilance01:19

Pharmacovigilance

860
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
860

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A retrospective, matched-tool comparison of the opioid risk tool (ORT) and revised opioid risk tool (ORT-R) in community pharmacy screenings.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Commending Public Health in a Time of Uncertainty.

Journal of public health management and practice : JPHMP·2025
Same author

Dare 2 Discuss social media campaign: An educational initiative to improve opioid use disorder discussions between the pharmacist and patient.

Journal of the American Pharmacists Association : JAPhA·2025
Same author

The role of pharmacy in promoting public health: Pharmacy and public health in 2050.

Journal of the American Pharmacists Association : JAPhA·2024
Same author

A faculty development series on race and ethnicity in pharmacy education.

Currents in pharmacy teaching & learning·2024
Same author

Revisiting the opioid and naloxone education (ONE) program: Program evaluation using the RE-AIM model four years later.

Research in social & administrative pharmacy : RSAP·2024

相关实验视频

Updated: Jul 12, 2025

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
12:20

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

21.2K

呼吁制定阿片类药物风险评估计划,在药房环境中实施.

Alyssa Hodges, Anna Skarphol, Mark A Strand

    Journal of the American Pharmacists Association : JAPhA
    |October 22, 2023
    PubMed
    概括

    一个经过验证的阿片类药物风险评估工具对于解决阿片类药物流行病至关重要. 这种工具可以指导临床决策,改善患者安全,并减少与阿片类药物使用相关的耻辱感.

    科学领域:

    • 公共卫生 公共卫生
    • 临床医学 临床医学
    • 药理学 药理学是指药理学的学科.

    背景情况:

    • 美国面临着严重的阿片类药物流行,需要基于证据的解决方案.
    • 目前对阿片类药物管理的方法需要改进,以优先考虑患者安全和适当的处方.

    研究的目的:

    • 倡导开发和实施经过验证的阿片类药物风险评估工具.
    • 强调将重点从处方量转移到处方适当性的重要性.
    • 强调医疗保健提供者需要非阿片类药物替代品和可访问的滥用资源.

    主要方法:

    • 审查目前打击阿片类药物流行病的战略.
    • 对理想的阿片类药物风险查工具 (透明度,特异性,验证) 的特征分析.
    • 讨论医疗保健提供者在患者护理和资源利用中的作用.

    主要成果:

    • 作为一个关键的解决方案,提出了一个统一的,经过验证的阿片类药物风险评估工具.
    • 该工具应指导临床决策,避免风险分数的"武器化".
    • 强调适当的处方,非阿片类药物治疗,以及提供者对当地资源的了解.

    结论:

    更多相关视频

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    7.1K
    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    9.7K

    相关实验视频

    Last Updated: Jul 12, 2025

    Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
    12:20

    Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior

    Published on: June 10, 2013

    21.2K
    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    7.1K
    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    9.7K
    • 实施标准化阿片类药物风险评估工具可以提高患者的安全性和护理.
    • 减少耻辱和确保患者尊严是阿片类药物使用管理的重要组成部分.
    • 转向以证据为基础,以患者为中心的战略是有效打击阿片类药物流行病的必要.